Halozyme Therapeutics (HALO) Cash & Equivalents (QoQ) (2010 - 2026)
Halozyme Therapeutics (HALO) Cash & Equivalents (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Halozyme Therapeutics | 9.65 Bn | 9.33 Bn | 297.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 131.47% |
| Dec 31, 2025 | -68.11% |
| Sep 30, 2025 | 578.40% |
| Jun 30, 2025 | -64.92% |
| Mar 31, 2025 | 52.20% |
| Dec 31, 2024 | -24.93% |
| Sep 30, 2024 | -17.86% |
| Jun 30, 2024 | 14.11% |
| Mar 31, 2024 | 39.08% |
| Dec 31, 2023 | -56.84% |
| Sep 30, 2023 | 23.99% |
| Jun 30, 2023 | 129.46% |
| Mar 31, 2023 | -58.84% |
| Dec 31, 2022 | 59.14% |
| Sep 30, 2022 | 61.83% |
| Jun 30, 2022 | -22.83% |
| Mar 31, 2022 | -0.74% |
| Dec 31, 2021 | -75.85% |
| Sep 30, 2021 | 10.00% |
| Jun 30, 2021 | -10.51% |